Intravenous immunoglobulin in the management of refractory lupus profundus.

Lupus

Division of Rheumatology, Department of Internal Medicine, 284697Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

Published: July 2022

Lupus profundus, often known as lupus panniculitis, is a rare form of persistent cutaneous lupus erythematosus. It usually manifests as painful plaques or nodules that can ulcerate and cause atrophy and scarring. It may respond to topical treatments and antimalarials, although treatment might be difficult at times, necessitating immunosuppressive medications. A 36-year-old woman from the United Arab Emirates presented with multiple painful disfiguring nodules involving the face and shoulders. The disfiguring skin nodules were resistant to systemic glucocorticoids, hydroxychloroquine, azathioprine, mycophenolate mofetil, and cyclosporine, but they significantly improved with monthly intravenous immunoglobulin over a 6-month period.

Download full-text PDF

Source
http://dx.doi.org/10.1177/09612033221099873DOI Listing

Publication Analysis

Top Keywords

intravenous immunoglobulin
8
lupus profundus
8
profundus lupus
8
immunoglobulin management
4
management refractory
4
lupus
4
refractory lupus
4
lupus panniculitis
4
panniculitis rare
4
rare form
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!